A dose-adjusted, open-label, pilot study of the safety, tolerability, and pharmacokinetics of STC3141 in critically ill patients with sepsis.
Bellomo R, Patava J, Van Lancker R, Layios N, Peetermans M, Plummer M, Attou R, McNamara R, Udy A, Wibrow B, Deane A, Litton E, Tanudji M, Su F, Zhong Z, Shi L, Ning L.
Bellomo R, et al. Among authors: tanudji m.
Pharmacol Res Perspect. 2024 Oct;12(5):e70015. doi: 10.1002/prp2.70015.
Pharmacol Res Perspect. 2024.
PMID: 39401149
Free PMC article.